{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:47:32Z","timestamp":1792450052105,"version":"4.5.0"},"reference-count":41,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"9","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Precis Oncol"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>\n                      Homozygous deletions of methylthioadenosine phosphorylase (\n                      <jats:italic toggle=\"yes\">MTAP<\/jats:italic>\n                      ) enzyme are common across human cancers and are associated with poor prognoses. Currently, to our knowledge, there are no approved therapies targeting\n                      <jats:italic toggle=\"yes\">MTAP<\/jats:italic>\n                      -deleted tumors, although there is significant ongoing research in this area. The aim of this study was to analyze the prevalence, clinical impacts, and comutational landscapes of patients with MTAP deletions in a network of community-based oncology clinics.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>We conducted retrospective analyses of clinicogenomic data from 21 community oncology practices in the Sarah Cannon Research Institute (SCRI) network. Clinical data from electronic health record systems, including drug administration dates, diagnosis dates, and molecular data from commercial next-generation sequencing vendors, were aggregated in SCRI's web-based precision medicine platform, Genospace. Overall survival (OS) and time to next therapy (TTNT) were analyzed using Kaplan-Meier plots and Cox proportional hazards regression. Patient data were deidentified before analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Among 10,936 patients analyzed in this study, 9.4% had homozygous\n                      <jats:italic toggle=\"yes\">MTAP<\/jats:italic>\n                      deletions (\n                      <jats:italic toggle=\"yes\">MTAP<\/jats:italic>\n                      -del).\n                      <jats:italic toggle=\"yes\">MTAP<\/jats:italic>\n                      -del was prevalent in glioblastoma (58.2%) and mesothelioma (40.5%) and least common in breast (4.0%) and colorectal cancers (1.4%). Overall,\n                      <jats:italic toggle=\"yes\">MTAP<\/jats:italic>\n                      -del patients had diminished OS (25.4 months\n                      <jats:italic toggle=\"yes\">v<\/jats:italic>\n                      52.1 months,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .0001), with pronounced deficits in\n                      <jats:italic toggle=\"yes\">MTAP<\/jats:italic>\n                      -del mesotheliomas (12.8 months\n                      <jats:italic toggle=\"yes\">v<\/jats:italic>\n                      23.0 months,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .0478) and urothelial carcinomas (22.9 months\n                      <jats:italic toggle=\"yes\">v<\/jats:italic>\n                      36.0 months,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .0549).\n                      <jats:italic toggle=\"yes\">MTAP<\/jats:italic>\n                      -del patients receiving chemotherapy had shortened TTNT intervals overall (8.1 months\n                      <jats:italic toggle=\"yes\">v<\/jats:italic>\n                      10.1 months,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .0002), and for urothelial (5.4 months\n                      <jats:italic toggle=\"yes\">v<\/jats:italic>\n                      6.4 months,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .0195) and gastroesophageal carcinomas (7.2 months\n                      <jats:italic toggle=\"yes\">v<\/jats:italic>\n                      8.8 months,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .0412).\n                      <jats:italic toggle=\"yes\">MTAP-<\/jats:italic>\n                      del patients had distinct mutational landscapes, compared with\n                      <jats:italic toggle=\"yes\">MTAP-<\/jats:italic>\n                      prof patients, including lower rates of TP53 mutation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">MTAP<\/jats:italic>\n                      is a key biomarker in precision oncology; this work describes the clinical outlook for these patients within the community-oncology setting. These insights can inform future study design, as\n                      <jats:italic toggle=\"yes\">MTAP<\/jats:italic>\n                      -directed therapies continue their development.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/po-25-00564","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T20:58:07Z","timestamp":1764968287000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":5,"title":["Clinical Presentation of\n                    <i>MTAP<\/i>\n                    Deletions in Real-World Settings: Lessons for the Clinical Development of Novel Targeted Therapies"],"prefix":"10.1200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2827-7143","authenticated-orcid":true,"given":"Jordan T.","family":"Best","sequence":"first","affiliation":[{"name":"Sarah Cannon Research Institute, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotong","family":"Fu","sequence":"additional","affiliation":[{"name":"Genospace, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8902-7164","authenticated-orcid":true,"given":"Sripraharsha S.","family":"Jampana Raju","sequence":"additional","affiliation":[{"name":"TriStar Centennial Medical Center, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Luckett","sequence":"additional","affiliation":[{"name":"Genospace, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Schlauch","sequence":"additional","affiliation":[{"name":"Genospace, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Bradley","sequence":"additional","affiliation":[{"name":"Sarah Cannon Research Institute, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6064-6837","authenticated-orcid":true,"given":"Vivek","family":"Subbiah","sequence":"additional","affiliation":[{"name":"Sarah Cannon Research Institute, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9874-1314","authenticated-orcid":true,"given":"Melissa L.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Sarah Cannon Research Institute, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3215-9465","authenticated-orcid":true,"given":"David R.","family":"Spigel","sequence":"additional","affiliation":[{"name":"Sarah Cannon Research Institute, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Howard","family":"Burris","sequence":"additional","affiliation":[{"name":"Sarah Cannon Research Institute, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5088-1876","authenticated-orcid":true,"given":"Andrew J.","family":"McKenzie","sequence":"additional","affiliation":[{"name":"Sarah Cannon Research Institute, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2855-5297","authenticated-orcid":true,"given":"Emma G.","family":"Sturgill","sequence":"additional","affiliation":[{"name":"Sarah Cannon Research Institute, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2003.11.016"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.12.010"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature08822"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-39608-2"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2014.04.017"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13587"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1593\/neo.05307"},{"key":"e_1_3_5_9_2","unstructured":"U.S. Department of Health and Human Services: National Institutes of Health National Library of Medicine and National Center for Biotechnology Information. https:\/\/clinicaltrials.gov\/search?term=MTAP%20Deletion&aggFilters=status:rec%20act"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23179780"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.03.043"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad5214"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-23-0669"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24240-3"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.18.00149"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djy221"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24028"},{"key":"e_1_3_5_18_2","volume-title":"FoundationOne\u00ae CDx Technical Information","author":"Foundation Medicine, Inc.","unstructured":"Foundation Medicine, Inc.: FoundationOne\u00ae CDx Technical Information, n.d. https:\/\/info.foundationmedicine.com\/hubfs\/FMI%20Labels\/FoundationOne_CDx_Label_Technical_Info.pdf"},{"key":"e_1_3_5_19_2","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2023","unstructured":"R Core Team: R: A Language and Environment for Statistical Computing. Vienna, Austria, R Foundation for Statistical Computing, 2023. https:\/\/www.R-project.org\/"},{"key":"e_1_3_5_20_2","unstructured":"Reference deleted"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-08167-5"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.42970"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57941-0"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15204978"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03823-8"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyae011"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.28376"},{"key":"e_1_3_5_28_2","unstructured":"Guardant Health: Guardant360 Assay Specifications. https:\/\/www.guardantcomplete.com\/assets\/pdf\/Guardant360-Specification-Sheet.pdf"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2693"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0095"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2004088"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-23-0816"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-022-01979-0"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02482174"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29397-z"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.3067"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.9116"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4971"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp-2023-209341"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2021.10.006"},{"key":"e_1_3_5_41_2","first-page":"326","article-title":"Clinical features of patients with MTAP-deleted bladder cancer","volume":"13","author":"De Souza AL","year":"2023","unstructured":"De Souza AL, Mega AE, Douglass J, et al: Clinical features of patients with MTAP-deleted bladder cancer. Am J Cancer Res 13:326-339, 2023","journal-title":"Am J Cancer Res"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.16036"}],"container-title":["JCO Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/PO-25-00564","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T20:58:10Z","timestamp":1764968290000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/PO-25-00564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1200\/PO-25-00564"],"URL":"https:\/\/doi.org\/10.1200\/po-25-00564","relation":{},"ISSN":["2473-4284"],"issn-type":[{"value":"2473-4284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"2025-06-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2500564"}}